Skip to content
ppharmaranks
Menu
Class IIOngoing

Children's Ibuprofen Oral Suspension recall

FDA recall D-0390-2026 · initiated Mar 2, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Mar 25, 2026How we research

STRIDES PHARMA INC recalled Children's Ibuprofen Oral Suspension in Mar 2026 — an FDA Class II recall (D-0390-2026) because Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot: 7261973A, 7261974A, Exp 01/31/2027

Quantity recalled: 89592 bottles

Details

Product
Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, Made in India, NDC 51672-5321-8.
Recalling company
Strides Pharma Intl
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S.A. Nationwide
Initiated
Mar 2, 2026
FDA report date
Mar 25, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Children's Ibuprofen Oral Suspension recalled?
STRIDES PHARMA INC recalled Children's Ibuprofen Oral Suspension in Mar 2026 — an FDA Class II recall (D-0390-2026) because Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Children's Ibuprofen Oral Suspension recalled?
Per the FDA enforcement record, the reason for recall D-0390-2026 was: Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.
Is a recalled Children's Ibuprofen Oral Suspension dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Children's Ibuprofen Oral Suspension are affected?
Distributed: U.S.A. Nationwide. The recall covers these lots — Lot: 7261973A, 7261974A, Exp 01/31/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0390-2026.

Source: openFDA Drug Enforcement record D-0390-2026

← All drug recalls